Where Are The Handcuffs? (Drugs)

law“One of Donald Trump’s few universally welcomed campaign promises was to do something about the prices of pharmaceutical drugs. Most Americans recognize that prices are too high, and are bothered by the rise of pharmaceutical price gouging…..

The key power is found in the “import relief” law — an important yet unused provision of the Medicare Modernization Act of 2003 that empowers the Food and Drug Administration to allow drug imports whenever they are deemed safe and capable of saving Americans money. The savings in the price-gouging cases would be significant. Daraprim, the antiparasitic drug whose price was raised by Mr. Shkreli to nearly $750 per pill, sells for a little more than $2 overseas. The cancer drug Cosmegen is priced at $1,400 or more per injection here, as opposed to about $20 to $30 overseas.

The remedy is simple: The government can create a means for pharmacies to get supplies from trusted nations overseas at much lower prices.” – Tim Wu

Karl Denninger – In other words Trump has the ability to administratively put a stop to the drug-price rape.

But let me point out that while this article is informative and points out a means by which Trump can irrespective of Congressional interference put a stop to the scam in one area of the medical system it ignores — intentionally — a much-larger and more-powerful hammer that every President has had available to them for the last 30 years and yet has refused to use.

Continue reading

More than half a million Americans spend more than $50,000 a year just on prescription medications

drugsMike Adams – It’s no secret that various industries increase customer pricing so the company can make a profit. That’s Economics 101. However, when prices surge so exorbitantly that the average person can barely afford an item while the company walks all the way to the bank, that’s Greed 101. Sadly, absurdly elevated prices permeate the marketplace, draining the wallets and energy of people in droves, and it particularly impacts those in need of life-saving medications.

A restaurant’s appetizer platter or some trendy bracelet charms are one thing, but when it comes to improving the quality of human lives or even saving them, people often have no choice but to pay steep prices. If you want to live, or live better, you’ll need to either win the lottery or have saved your pennies since childhood. It’s not fair, but it’s a shocking reality.

An eye-opening look at how we’re being ripped off by drug companies

Look at the numbers:

Almost overnight, Turing Pharmaceuticals raised the price for Daraprim, a treatment that fights life-threatening parasitic infections from $13.50 per pill to a whopping $750 a pill. The company’s mogul, Martin Shkreli, justified this drastic increase by saying that it’s simply about keeping business going strong, and he even went so far as to say that the increase doesn’t deserve the widespread criticism it is receiving.

When it comes to treating leukemia, it has been estimated that the actual cost for a year’s supply of Gleevec (generic name imatinib), is an affordable $159. However, in the United States, it costs people suffering with the illness more than $106,000 annually; in the United Kingdom, it costs more than $30,000 each year.

The insanity continues. Continue reading

Outrageous Big Pharma greed on parade as $1 pill skyrockets to $750 PER PILL

Big PharmaMike Adams – The total greed of Big Pharma is on parade this week as a company called Turing Pharmaceuticals took ownership of a lifesaving medication that treats parasitic infections like malaria. The pill — mostly purchased by AIDS and cancer patients — used to cost $1 each. But now, thanks to Turing Pharmaceuticals and its profiteering CEO Martin Shkreli, each pill will cost you $750.

Remarkably, The New York Times even covered the story, reporting, “Specialists in infectious disease are protesting a gigantic overnight increase in the price of a 62-year-old drug that is the standard of care for treating a life-threatening parasitic infection.”

“The drug, called Daraprim, was acquired in August by Turing Pharmaceuticals, a start-up run by a former hedge fund manager. Turing immediately raised the price to $750 a tablet from $13.50, bringing the annual cost of treatment for some patients to hundreds of thousands of dollars.”

This drug was priced at just $1 a few years ago. It went up to $13.50 over the last decade or so, and now has spiked to $750 per pill. This means a single treatment course could cost more than buying a home.

This is all explained by the “Taiwanese animators” in this highly educational animated short video:

[youtube=https://youtu.be/CtPta0TgP34]

Big Pharma greed on parade and out of control

Why is Turing Pharmaceuticals charging $750 a pill? Because they CAN. Like every other drug company in the world, they’re going to gouge the consumer and extract the maximum dollars possible. Big Pharma is really about the profits, you see, and not at all interested in “helping humanity” as their ridiculous TV ads claim. Continue reading